Skip to main content

Day: April 20, 2023

Texas Capital Bancshares, Inc. Announces First Quarter 2023 Results

First quarter 2023 net income of $38.7 million and net income available to common stockholders of $34.3 million, or $0.70 per diluted share; both declining $1.0 million compared to first quarter 2022 First quarter 2023 Pre-Provision Net Revenue(1) grew $28.0 million (55%) compared to first quarter 2022 Top tier liquidity and capital ratios maintained, enabling continued execution of the strategic plan; Cash andSecurities to Total Assets of 28.0% and Tangible Common Equity to Tangible Assets(2) of 9.7% Total deposits declined 3%; continuing communicated execution of long-term deposit mix shift away from highest cost sources DALLAS, April 20, 2023 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, announced operating results for the first quarter of 2023. Net income available...

Continue reading

Correction: WithSecure Corporation’s Interim report January-March 2023

WithSecure Corporation, Interim report (correction) January-March 2023, 20 April 2023 at 12:30 EEST Correction: WithSecure Corporation’s Interim report January-March 2023 WithSecure Corporation corrects the revenue by geographical area disclosure presented in Note 2 (Segment information) of the Interim report January-March 2023 that was published on 20 April 2023 at 8:00 am EEST. Revenue by geographic area was incorrectly disclosed. Corrected table for Note 2 (Segment information, Disaggregation of revenue, By geographical area) on page 21 of the report is shown below. Corrected Interim report is attached to this release, and updated to the company website Materials | Investor Relations | WithSecure™By geographical area 1–3/2023 1–3/2022 1–12/2022Nordic countries 10,811 10,022 40,985Rest of Europe 15,820 13,812 60,383North...

Continue reading

Talenom Plc’s Business Review January-March 2023: Growth continued as strong in line with the selected strategy

Talenom Plc, Stock exchange release, 20 April 2023 at 9:00 EEST Talenom Plc’s Business Review January-March 2023: Growth continued as strong in line with the selected strategy January–March 2023 in briefNet sales EUR 31.3 million (25.2), growth 24.2% (24.1) EBITDA EUR 8.4 million (8.9), 26.7% (35.2) of net sales Operating profit (EBIT) EUR 3.5 million (4.9), 11.0% (19.3) of net sales Net profit EUR 2.1 million (3.7) Earnings per share EUR 0.05 (0.09)Key figuresGroup 1–3/2023 1–3/2022 Change, %Net sales, EUR 1,000 31,311 25,209 24.2%Net sales, increase % 24.2% 24.1%  EBITDA, EUR 1,000 8,365 8,864 -5.6%EBITDA of net sales, % 26.7% 35.2%  Operating profit (EBIT), EUR 1,000 3,458 4,861 -28.9%Operating profit (EBIT), as % of net sales 11.0% 19.3%  Return on investment (ROI), % (rolling 12 months) 11.7% 16.8%  Interest-bearing...

Continue reading

RoodMicrotec N.V. publishes 2022 annual report with audited financial statements

RoodMicrotec shows strong financial performance for the year 2022.Total income of EUR 16.5 million with an EBITDA of EUR 3.9 million Net profit of EUR 2.4 million Cash flow from operating activities of EUR 3.6 millionDeventer, April 20, 2023 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, today publishes the Company’s Annual Report for the financial year 2022 including the audited consolidated and company financial statements. The 2022 Annual Report is available for download on the corporate website: www.roodmicrotec.com/en/investor-relations-en/financial-publications. The total income for 2022 amounted to EUR 16.5 million, which is 14% higher than in 2021 (EUR 14.5 million) resulting in a second consecutive year with double-digit growth. Notably, this is the highest total income...

Continue reading

Tryg A/S – Q1 report 2023

 Tryg’s Supervisory Board has today approved the interim report for Q1 2023*. Tryg is reporting for the first time under the new accounting standard, IFRS 17, in line with the insurance sector. Tryg has published comprehensive re-stated figures under IFRS 17 at the end of March, these are available on Tryg.com. The insurance service result target for 2024 under IFRS 17 has been increased from DKK 7.0-7.4bn to DKK 7.2-7.6bn driven primarily by a reclassification of insurance operating expenses. Tryg is also updating its expense ratio target to ~13.5% (~14.0%) while the combined ratio target at or below 82% is unchanged. Tryg reported a Q1 insurance service result of DKK 1,474m (DKK 1,014m), driven by a positive top-line development, across all business units, good development in the core business including the delivery of the RSA Scandinavia...

Continue reading

Bufab Group: Interim report January – March 2023

Strong start to the year with continued healthy growth in both sales and operating profit, and a robust improvement in cash flow First quarter of 2023Net sales increased by 19 percent to SEK 2,386 million (2,002). Organic growth was 0 percent and order intake was somewhat lower than net sales Operating profit (EBITA) increased by 33 percent to SEK 323 million (243) and the operating margin was 13.5 percent (12.1). Adjusted for items affecting comparability related to the closure of the Russian operations of SEK 0 million (-15), remeasured additional purchase considerations of SEK -2 million (-15) and acquisition costs of SEK 0 million (-8), operating profit increased by 16 percent to SEK 325 million (281), corresponding to an adjusted operating margin of 13.6 percent (14.0) Earnings per share increased by 21 percent to SEK 5.33 (4.42) Operating...

Continue reading

Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023

PRESS RELEASE: REGULATED INFORMATION20 April 2023, 07:00 CEST Biocartis Reports Results of First Quarter of 2023:16% Growth of Oncology Cartridge RevenuesGross Margin on Products of 37% and EBITDA of EUR -8.4m Mechelen, Belgium, 20 April 2023 – Biocartis Group NV (the “Company” or “Biocartis”), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update for the first quarter of 2023 and the outlook for the full year 2023. Commenting on the Q1 2023 results, Herman Verrelst, Chief Executive Officer of Biocartis, said: “The start of 2023 was broadly in line with our expectations, with 16% growth of cartridge revenues in our core oncology business and a 35% gross margin. While we still expect to grow such product related revenues by 25-30% for the entire year, we saw Q1 2023...

Continue reading

Coop Pank unaudited financial results for Q1 2023

By the end of the Q1 2023, Coop Pank had 155,000 customers, during the quarter the number of customers increased by 8,200 (+6%). The bank had 70,100 active customers, during the quarter the number of active customers increased by 3,300 (+5%). In Q1 2023, volume of deposits in Coop Pank increased by 5 million euros (+0.3%), reaching total of 1.51 billion euros. Deposits from private clients showed the fastest growth, increasing by 27 million euros: demand deposits decreased by 7 million euros and term deposits increased by 34 million euros. Deposits from domestic companies decreased by 23 million euros: demand deposits decreased by 94 million euros and term deposits increased by 71 million euros. Deposits from international deposit platform Raisin and other financing increased by 1 million euro. Compared to Q1 2022, volume of Coop Pank’s...

Continue reading

WithSecure Corporation interim report January-March 2023: Cloud revenue growth 31%, consulting impacted by uncertainty of the financial sector

WithSecure Corporation, Interim report January-March 2023, 20 April 2023 at 8:00 EEST Interim Report 1 January – 31 March 2023 (“1st quarter” or “Q1 2023”) WithSecure Corporation interim report January-March 2023: Cloud revenue growth 31%, consulting impacted by uncertainty of the financial sector Highlights of January – March 2023Annual Recurring Revenue (ARR)1 for cloud products2 increased by 27% to EUR 81.5 million (EUR 64.1 million) ARR growth from previous quarter was 2 % Net Revenue Retention for cloud products was 110% Revenue from cloud products increased by 31% to EUR 19.9 million (EUR 15.2 million) Revenue from on-premise products decreased by 11% to EUR 6.4 million (EUR 7.1 million) Revenue from cyber security consulting decreased by 10% to EUR 8.9 million (EUR 10.0 million) Adjusted EBITDA was EUR -6.2 million (EUR -5.2 million...

Continue reading

Aspocomp’s Interim Report January 1-March 31, 2023: Net sales at the level of the comparison period, the order book strengthened significantly from the turn of the year

Aspocomp Group Plc, Interim Report, April 20, 2023, at 8:00 a.m. EEST FIRST QUARTER 2023 HIGHLIGHTSNet sales EUR 8.9 (9.0) million, decrease of 1% Operating result EUR 0.3 (0.8) million, 3.8% (8.9%) of net sales Earnings per share EUR 0.04 (0.11) Operative cash flow EUR 1.6 (0.7) million Orders received EUR 13.7 (13.0) million, increase of 5% Order book at the end of the review period EUR 19.1 (20.5) million, decrease of 7% Equity ratio 72.9% (66.9%)OUTLOOK FOR 2023 Inflation and interest rates, the risk of recession and the uncertainties posed by Russia’s war of aggression will affect the operating environment of the company and its customers in the financial year 2023. The cycle of the Semiconductor Industry segment is expected to return to growth in the second half of the year. Aspocomp reiterates the guidance that was published...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.